Acquisition Combines Lab Glassware Suppliers Wheaton and Duran Group
The Duran Group’s acquisition of Wheaton combine two brands of laboratory consumables.
Wheaton, a Millville, NJ-based provider of laboratory glassware and consumables, announced on Sept. 15, 2015, that it has been acquired by Duran Group, a portfolio company of funds advised by One Equity Partners Capital Advisors L.P. (OEP) that manufactures specialty glass solutions for the laboratory and industrial glass markets.
The combined company will benefit from a broader base from which to grow their portfolio of products, according to a press statement announcing the merger. Wheaton provides glass and plasticware in North America; Duran provides laboratory glassware in Europe. Both companies also serve Asia and other global markets.
“This acquisition represents a new chapter for Wheaton and will allow us to accelerate a number of growth programs already in progress. Joining a company with the expertise and capabilities of Duran Group additionally opens up many possibilities for improvements and growth,” said Wayne Brinster, president and CEO of Wheaton. “In the areas of products, infrastructure, talent and focus, the two organizations complement each other very well.”
OEP has managed approximately $11 billion in total investments and committed capital for JPMorgan Chase & Co. since 2001.
Source: Wheaton
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.
